Skip to main content

Find Clinical Trials

Home
Conditions
Adenocarcinoma

Clinical trial condition

Adenocarcinoma

Explore clinical trials studying Adenocarcinoma. Study availability and eligibility vary by location and protocol.

5,067 public trials 1,185 recruiting studies

Refine in advanced search Browse all conditions

Adenocarcinoma trial results

Not yet recruiting

SIRT and Peri-immunotherapy : a New Concept

NCT06971237

Conditions: Adenocarcinoma, Advanced Hepatocellular Carcinoma (HCC), Classified as BCLC Stage B or C, Treated With a Combination of Selective Internal Radiation Therapy, Carcinoma, +9 more
Locations: Hôpital Paul Brousse - Radiology Department Villejuif, France

View Trial Details

Not yet recruiting

Necessity of TSH Suppression Therapy in Active Surveillance for Thyroid Cancer Patients.

NCT06971965

Conditions: Adenocarcinoma, Adenocarcinoma, Papillary, Carcinoma, +12 more
Locations: Not specified

View Trial Details

Not yet recruiting

Virtual Renality: Assessing the Impact of Virtual Reality on Preoperative Planning in Renal Cancer Surgery

NCT06960174

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations: Not specified

View Trial Details

Not yet recruiting

Iparomlimab and Tuvonralimab Injection (QL1706) Combined With Bevacizumab for Postoperative Adjuvant Therapy in Hepatocellular Carcinoma (HCC) With High Risk of Recurrence

NCT06958484

Conditions: Adenocarcinoma, Adjuvant Treatment, Carcinoma, +10 more
Locations: Not specified

View Trial Details

Not yet recruiting

Shared Decision-Making for Determining Treatment Strategies in Low-Risk Thyroid Cancer

NCT06730893

Conditions: Adenocarcinoma, Adenocarcinoma, Papillary, Carcinoma, +12 more
Locations: Not specified

View Trial Details

Not yet recruiting

Second-line Regimen Combined With Radiotherapy Versus Without Radiotherapy in Patients With Locally Advanced/Oligometastatic ICC After Failure of First-line Treatment：an Open-label, Randomized, Controlled Phase II Clinical Study

NCT06946849

Conditions: Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +5 more
Locations: Zhongshan Hospital, Fudan University Shanghai, Shanghai Municipality, China

View Trial Details

Not yet recruiting

Relationship Between FGF19 Overexpression and Disease Prognosis

NCT06938451

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Beijing Tsinghua Changgung Hospital Beijing, China

View Trial Details

Not yet recruiting

The Epidemiology of Patients Treated With ATZ+BEV in Real Life Setting

NCT06903663

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Fundeni Clinical Institute Bucharest, Romania

Regional Institute of Gastroenterology and Hepatology "Prof. Dr. Octavian Fodor" Cluj-Napoca, Cluj, Romania

Regional Institute of Oncology Iași, Iaşi, Romania

Oncohelp Timișoara, Timiș County, Romania

View Trial Details

Not yet recruiting

Efficacy and Safety of Liver Transplantation for Hepatocellular Carcinoma With Bile Duct Tumor Thrombus: a Single-arm, Multicenter, Prospective Study (HCC-BDTT in LT)

NCT06928415

Conditions: Adenocarcinoma, Bile Duct Tumor Thrombus, Carcinoma, +11 more
Locations: Not specified

View Trial Details

Not yet recruiting

Effect of Biejia-Ruangan Compound on Survival Rate and Recurrence Rate of Hepatocellular Carcinoma After Radical Treatment

NCT06923176

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Not specified

View Trial Details